Medicinal product name Bortezomib Fresenius Kabi
Pharmaceutical form Powder for solution for injection
Strength 3.5 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/19/1397/001N1 Is available
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L01XG01 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(30 containers)
Recipe Plus N1
(3,5 mg)
Glass vial 559.93  EU/1/19/1397/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/19/1397/001
Date of authorisation Nov 14, 2019
Marketing authorisation holder, country Fresenius Kabi Deutschland GmbH, Germany